Abstract
The report covers a forecast and an analysis of the gout therapeutics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the gout therapeutics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the gout therapeutics market on a global level.
In order to give the users of this report a comprehensive view of the gout therapeutics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the gout therapeutics market by segmenting it based on drug type, disease condition, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some key players in the global gout therapeutics market include Teijin Pharma, Takeda Pharmaceutical, Novartis, Mylan, Horizon Pharma, Teva Pharmaceutical, Iroko Pharmaceuticals, Hikma Pharmaceuticals, and Merck.
This report segments the global gout therapeutics market as follows:
Global Gout Therapeutics Market: Drug Type Analysis
Colchicine
Antihyperuricemic Agents
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Biologics
Global Gout Therapeutics Market: Disease Condition Analysis
Acute Gout
Chronic Gout
Global Gout Therapeutics Market: Distribution Channel Analysis
Retail Pharmacy
Hospital Pharmacy
Online Sales
Global Gout Therapeutics Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa